Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiaan Remmers

Showing results (1-10 of 95) with videos related to

Pageof 10
Sort By:
International Journal of Cancer|May 13, 2020
Personalized strategies in population screening for prostate cancerSebastiaan Remmers, Monique J Roobol
European Urology Open Science|May 15, 2023
The Patient Journey from Randomization to Detection of Prostate Cancer and Death: Results from ERSPC RotterdamSebastiaan Remmers, Daan Nieboer, Monique J Roobol, et al.
Experimental Psychology|October 28, 2020
The Influence of Poststudy Action Congruency on Memory ConsolidationRené Zeelenberg, Sebastiaan Remmers, Florence Blaauwgeers, et al.
European Urology|February 18, 2024
Reply to Borivoj Golijanin, Anthony Mega, and Dragan Golijanin's Letter to the Editor re: Ivo I. de Vos, Sebastiaan Remmers, Renée Hogenhout, Monique J. Roobol, ERSPC Rotterdam Study Group. Prostate Cancer Mortality Among Elderly Men After Discontinuing Organised Screening: Long-term Results from the European Randomized Study of Screening for Prostate Cancer Rotterdam. Eur Urol 2024;85:74-81Ivo I de Vos, Sebastiaan Remmers, Monique J Roobol
ANZ Journal of Surgery|June 27, 2025
External Validation of MRI-Based Prostate Cancer Risk Calculators in an Australian CohortNicole Williams, Sebastiaan Remmers, Alex Jay, et al.
European Urology|November 2, 2023
Prostate Cancer Mortality Among Elderly Men After Discontinuing Organised Screening: Long-term Results from the European Randomized Study of Screening for Prostate Cancer RotterdamIvo I de Vos, Sebastiaan Remmers, Renée Hogenhout, et al.
European Urology|April 7, 2023
A Detailed Evaluation of the Effect of Prostate-specific Antigen-based Screening on Morbidity and Mortality of Prostate Cancer: 21-year Follow-up Results of the Rotterdam Section of the European Randomised Study of Screening for Prostate CancerIvo I de Vos, Annick Meertens, Renée Hogenhout, et al.
Prostate Cancer and Prostatic Diseases|January 11, 2023
The transition from transrectal to transperineal prostate biopsy without antibiotic prophylaxis: Cancer detection rates and complication ratesRenée Hogenhout, Sebastiaan Remmers, Geert J L H van Leenders, et al.
European Urology Open Science|January 31, 2022
Reducing Biopsies and Magnetic Resonance Imaging Scans During the Diagnostic Pathway of Prostate Cancer: Applying the Rotterdam Prostate Cancer Risk Calculator to the PRECISION Trial DataSebastiaan Remmers, Veeru Kasivisvanathan, Jan F M Verbeek, et al.
BJUI Compass|August 11, 2022
Reducing prostate biopsies and magnetic resonance imaging with prostate cancer risk stratificationPetter Davik, Sebastiaan Remmers, Mattijs Elschot, et al.
Pageof 10

Showing results (1-10 of 95) with videos related to

Sort By:
Pageof 10
International Journal of Cancer|May 13, 2020
Personalized strategies in population screening for prostate cancerSebastiaan Remmers, Monique J Roobol
European Urology Open Science|May 15, 2023
The Patient Journey from Randomization to Detection of Prostate Cancer and Death: Results from ERSPC RotterdamSebastiaan Remmers, Daan Nieboer, Monique J Roobol, et al.
Experimental Psychology|October 28, 2020
The Influence of Poststudy Action Congruency on Memory ConsolidationRené Zeelenberg, Sebastiaan Remmers, Florence Blaauwgeers, et al.
European Urology|February 18, 2024
Reply to Borivoj Golijanin, Anthony Mega, and Dragan Golijanin's Letter to the Editor re: Ivo I. de Vos, Sebastiaan Remmers, Renée Hogenhout, Monique J. Roobol, ERSPC Rotterdam Study Group. Prostate Cancer Mortality Among Elderly Men After Discontinuing Organised Screening: Long-term Results from the European Randomized Study of Screening for Prostate Cancer Rotterdam. Eur Urol 2024;85:74-81Ivo I de Vos, Sebastiaan Remmers, Monique J Roobol
ANZ Journal of Surgery|June 27, 2025
External Validation of MRI-Based Prostate Cancer Risk Calculators in an Australian CohortNicole Williams, Sebastiaan Remmers, Alex Jay, et al.
European Urology|November 2, 2023
Prostate Cancer Mortality Among Elderly Men After Discontinuing Organised Screening: Long-term Results from the European Randomized Study of Screening for Prostate Cancer RotterdamIvo I de Vos, Sebastiaan Remmers, Renée Hogenhout, et al.
European Urology|April 7, 2023
A Detailed Evaluation of the Effect of Prostate-specific Antigen-based Screening on Morbidity and Mortality of Prostate Cancer: 21-year Follow-up Results of the Rotterdam Section of the European Randomised Study of Screening for Prostate CancerIvo I de Vos, Annick Meertens, Renée Hogenhout, et al.
Prostate Cancer and Prostatic Diseases|January 11, 2023
The transition from transrectal to transperineal prostate biopsy without antibiotic prophylaxis: Cancer detection rates and complication ratesRenée Hogenhout, Sebastiaan Remmers, Geert J L H van Leenders, et al.
European Urology Open Science|January 31, 2022
Reducing Biopsies and Magnetic Resonance Imaging Scans During the Diagnostic Pathway of Prostate Cancer: Applying the Rotterdam Prostate Cancer Risk Calculator to the PRECISION Trial DataSebastiaan Remmers, Veeru Kasivisvanathan, Jan F M Verbeek, et al.
BJUI Compass|August 11, 2022
Reducing prostate biopsies and magnetic resonance imaging with prostate cancer risk stratificationPetter Davik, Sebastiaan Remmers, Mattijs Elschot, et al.
Pageof 10